Seviteronel

DB12275InvestigationalSmall molecule

Seviteronel has been used in trials studying the treatment of CRPC, Prostate Cancer, and Castration-resistant Prostate Cancer.

Chemical structure of Seviteronel
Mechanism
Curator reviewed
Formula / weight
C18H17F4N3O3 · 399.346 g/mol (avg)
Code names
VT-464

Resolves to

Compound
UNII8S5OIN36X4CAS1610537-15-9ChEMBLCHEMBL3264610PubChem78357816
Structure
InChIKeyZBRAJOQFSNYJMF-SFHVURJKSA-NSMILESCC(C)[C@@](O)(C1=CN=NN1)C1=CC=C2C=C(OC(F)F)C(OC(F)F)=CC2=C1
Targets
P10275ARP05093CYP17A1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Seviteronel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In